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Store-operated Ca2+ entryTwo-pore channels (TPCs) are NAADP-sensitive receptor channels that conduct Ca2+ efﬂux from the intra-
cellular stores. Discharge of the internal Ca2+ pools results in the activation of store-operated Ca2+ entry
(SOCE); however, the role of TPCs in the modulation of SOCE remains unexplored. Mammalian cells express
three TPCs: TPC1, TPC2 and TPC3, a pseudogene in humans. Here we report that MEG01 and HEK293 cells
endogenously express TPC1 and TPC2. Silencing TPC2 expression results in attenuation of the rate and extent
of thapsigargin (TG)-evoked SOCE both in MEG01 and HEK293 cells, without having any effect on the ability
of cells to accumulate Ca2+ into the TG-sensitive stores. Similarly, silencing of native TPC2 expression
reduced thrombin-induced Ca2+ entry in MEG01 cells. In contrast, silencing of TPC1 expression was without
effect either on TG or thrombin-stimulated Ca2+ entry both inMEG01 and HEK293 cells. Biotinylation analysis
revealed that TPC1 and TPC2 are expressed in internal membranes. Finally, co-immunoprecipitation experi-
ments indicated that endogenously expressed TPC2, but not TPC1, associates with STIM1 and Orai1, but not
with TRPC1, in MEG01 cells with depleted intracellular Ca2+ stores, but not in resting cells. These results
provide strong evidence for the modulation of SOCE by TPC2 involving de novo association between TPC2
and STIM1, as well as Orai1, in human cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Store-operated calcium entry (SOCE) is a mechanism for Ca2+
inﬂux controlled by the ﬁlling state of the intracellular Ca2+ stores
[1]. The activation of SOCE has been reported to involved the partici-
pation of the stromal interaction molecule-1 (STIM1) [2–4], identiﬁed
both as a membrane surface protein in stromal cells [5], and, predom-
inantly, in the membranes of the endoplasmic reticulum (ER) [6] and
certain acidic Ca2+ stores [7]. STIM1 located in the membrane of the
internal Ca2+ stores expresses the Ca2+ binding domain (the EF hand
motif) within the ER lumen. Hence, when the intraluminal Ca2+ con-
centration decreases STIM1 re-localizes at sites of close proximity to
the plasmamembrane (PM) and the ER membrane, allowing its associ-
ation with members of the Orai and TRPC families [8–10].
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l rights reserved.STIM1 and the store-operated channels (SOCs). Ca2+-dependent inac-
tivation of SOCs is inﬂuenced by mitochondria, which, either directly
or through the activation of ATP-dependent Ca2+ clearance mecha-
nisms [11], is able to buffer Ca2+ entering the cell [12] and STIM1
function is controlled by the intraluminal Ca2+ concentration, which
is ﬁnely modulated by the interplay between closely located sarco/
endoplasmic reticulum Ca2+ ATPases [13,14] and receptors for intra-
cellular Ca2+-mobilizing diffusible molecules.
In mammalian cells, intracellular Ca2+ mobilizing molecules
include the inositol 1,4,5-trisphosphate (IP3), cyclic ADP ribose or
nicotinic acid adenine dinucleotide phosphate (NAADP). While a role
for IP3 and cyclic ADP ribose (ryanodine) receptors in the regulation
of Ca2+ inﬂux has long been proposed [15–17], a possible role for
NAADP receptors in SOCE or other mechanisms for Ca2+ inﬂux is
unknown. Three NAADP-regulated receptors/channels have been
identiﬁed as two-pore channels (TPC), with TPC1 and TPC2 both
mediating NAADP-induced Ca2+ release, and TPC3, a pseudogene in
humans and other primates [18,19]. TPC1 is predominantly localized
in endosomes while TPC2 has been mostly identiﬁed in lysosome-
related organelles [18,20], cellular compartments that have been
presented as agonist-releasable Ca2+ stores in different cell types
[7,21,22], with the ability to activate SOCE [23]. Despite, photoafﬁnity
labeling of high afﬁnity NAADP binding sites has demonstrated
that this messenger molecule binds to an accessory protein rather
than directly to TPCs both in mammalian cells [24] and sea urchin
eggs [25], NAADP is the only known physiological modulator of
TPCs.
1977J.J. López et al. / Biochimica et Biophysica Acta 1823 (2012) 1976–1983In the present study we have investigated the possible role of TPC1
and TPC2 in SOCE in two unrelated mammalian cells, the
megakaryoblastic cell line MEG01 and HEK-293. Our results indicate
that, while TPC1 and TPC2 are expressed in both cell types, TPC1
knockdown was without effect in SOCE and silencing of TPC2 expres-
sion results in a signiﬁcant attenuation of SOCE probably mediated by
the interaction with STIM1 and Orai1, which suggest a functional role
for TPC2 in the modulation of SOCE.
2. Materials and methods
2.1. Materials
Fura-2 acetoxymethyl ester (fura-2/AM) and calcein were from
Invitrogen (Madrid, Spain). Thrombin, thapsigargin (TG), leupeptin,
benzamidine, phenyl methyl sulphonyl ﬂuoride (PMSF), sodium
dodecyl sulfate (SDS), rabbit anti-Orai1 antibody (C-terminal), rabbit
anti-TPC2 antibody, nonidet P-40 and bovine serum albumin (BSA)
were from Sigma (Madrid, Spain). Mouse anti-STIM1 antibody was
from BD Transduction Laboratories (Franklin Lakes, NJ, U.S.A.). Rabbit
anti-TRPC1 polyclonal antibody was obtained from Antibodies-online
GmbH (Aachen, Germany). Goat anti-TPC1 antibody, horseradish
peroxidase-conjugated donkey anti-goat IgG antibody and horseradish
peroxidase-conjugated goat anti-rabbit IgG antibody were from Santa
Cruz Biotechnology (Santa Cruz, CA, U.S.A.). Horseradish peroxidase-
conjugated ovine anti-mouse IgG antibody (NA931) and hyperﬁlm
ECL were from Amersham (Buckinghamshire, U.K.). Transpass COS/
293 transfection reagent was from Izasa (Madrid, Spain). Protein
A-agarose was from Upstate Biotechnology Inc. (Madrid, Spain).
Enhanced chemiluminescence detection reagents were from Pierce
(Cheshire, U. K.). All other reagents were of analytical grade.
2.2. Cell culture
The human megakaryoblastic cell line MEG01 and HEK-293 cells
were obtained from ATCC (Manassas, VA, USA) and cultured at 37 °C
with a 5% CO2 in RPMI or DMEM media, respectively, supplemented
with 10% fetal calf serum, 2 mM L-glutamine and50 μg/mL gentamycin.
shRNA, complementary oligonucleotides corresponding to a
TPC1 target sequence (5′-CGAGCTGTATTTCATCATGAA-3′), TPC2 tar-
get sequence (5′‐CAGGTGGGACCTCTGCATTGA-3′) or scramble RNA
(scRNA) as control (5′-AATTCTCCGAACGTGTCACGT-3′) were kindly
provided by Dr. Patel and described previously [20]. Cells were tran-
siently transfected with shRNA using the Amaxa Nucleofection system
(for MEG01 cells) or transpass COS/293 transfection reagent (for HEK-
293 cells), and used 1–3 d after transfection as previously described [7].
Cell viability was assessed using calcein and trypan blue. For calcein
loading, cells were incubated for 30 minwith 5 μMcalcein-AMat 37 °C,
centrifuged and the pellet was resuspended in fresh HBS. Fluorescence
was recorded from 2 mL aliquots using a Cary Eclipse spectrophotome-
ter (Varian Ltd, Madrid, Spain). Samples were excited at 494 nm and
the resulting ﬂuorescence was measured at 535 nm. The results
obtained with calcein were conﬁrmed using the trypan blue exclusion
technique. 95% of the cells were viable in our preparations.
2.3. RT-PCR
Total RNA was extracted from MEG01 and HEK293 cells using
TRIzol® reagent (Invitrogen, Carlsbad, CA) according to manufacturer
speciﬁcations, and reverse-transcribed to single-strand cDNA using
SuperScript® VILO™ cDNA Synthesis Kit (Invitrogen, Carlsbad, CA).
Single-strand cDNA products were directly used for PCR ampliﬁcation
performed with an Eppendorff Mastercycler® thermal cycler
(Eppendorf AG, Hamburg-Eppendorf, Germany). PCR reagents were
purchased from TAKARA (Takara Bio Inc., Otsu, Shiga, Japan). PCR
products were obtained using the following cycling conditions: 96 °C2 min, followed by 35 cycles of 96 °C 15 s, 56 °C 25 s, 72 °C 30 s, and
ﬁnishedwith 72 °C 10 min. The following primerswere used to amplify
human TPC (hTPC) cDNA transcripts; hTPC1_F: 5-ttctgtgttttgctttaggg-3
and hTPC1_R: 5-attccgcttccattagatcc-3: hTPC2_F: 5-gtttgacatggagagaa
ccttgac-3 and hTPC2_R: 5-gatgaaaataactggcaatcagaacc-3 [20]. PCR
products were separated by electrophoresis in 1.5% agarose gels
(Roth, Germany) and the resulting bands were documented and subse-
quently isolated fromgels using UltraClean® PCR Clean-Up Kit (MO BIO
Laboratories Inc., Carlsbad, CA). The ampliﬁcation of hTPC transcripts
was conﬁrmed by sequenciation of the PCR products (STAB- SAIUex,
University of Extremadura, Spain).
2.4. Measurement of intracellular free calcium concentration ([Ca2+]i)
Cells were loaded with fura-2 by incubation with 2 μM fura 2/AM
for 45 min at 37 °C. Coverslips with cultured cells were mounted on a
perfusion chamber and placed on the stage of an epiﬂuorescence
inverted microscope (Nikon Diaphot T200, Melville, NY, USA) with
image acquisition andanalysis system for videomicroscopy (Hamamatsu
Photonics, Hamamatsu, Japan). Cells were continuously superfused with
HEPES-buffered saline containing (HBS in mM): 145 NaCl, 10 HEPES, 10
D-glucose, 5 KCl, 1 MgSO4, pH 7.45, and supplemented with 0.1% (w/v)
BSA. Cellswere alternatively excitedwith light fromaxenon lamppassed
through a high-speed monochromator (Polychrome IV, Photonics,
Hamamatsu, Japan) at 340/380 nm. Fluorescence emission at 505 nm
was detected using a cooled digital CCD camera (Hisca CCD C-6790,
Hamamatsu, Japan) and recorded using Aquacosmos 2.5 software,
(Hamamatsu Photonics, Hamamatsu, Japan).
Ca2+ entry was estimated using the integral of the rise in fura 2
ﬂuorescence 340/380 nm ratio for 2 min after addition of CaCl2.
Ca2+ release was estimated using the integral of the rise in fura 2 ﬂuo-
rescence 340/380 nm ratio for 2 min after the addition of thrombin or
TG [26].
To calculate the initial rate of Ca2+ elevation after the addition of
Ca2+ to the medium, the traces were ﬁtted to the equation y=
A+KX, where K is the slope.
2.5. Immunoprecipitation and Western blotting
The immunoprecipitation and Western blotting were performed
as described previously [27,28]. Brieﬂy, 500 μL aliquots of cell suspen-
sions (5×106 cells/mL) were lysed with an equal volume of Nonidet
P-40 buffer, pH 8, containing 274 mM NaCl, 40 mM Tris, 20% glycerol,
4 mM EGTA, 2% nonidet P-40, 2 mM Na3VO4, 2 mM PMSF, 100 μg/mL
leupeptin and 10 mM benzamidine. Aliquots of cell lysates (1 mL)
were immunoprecipitated by incubation with 2 μg of anti-hTRPC1
antibody, anti-STIM1 antibody or anti-Orai1 antibody and 25 μL of
protein A-agarose overnight at 4 °C on a rocking platform. The immu-
noprecipitates were resolved by 10% SDS-PAGE and separated proteins
were electrophoretically transferred onto nitrocellulose membranes for
subsequent probing. Blots were incubated overnight with 10% (w/v)
BSA in tris-buffered saline with 0.1% Tween 20 (TBST) to block residual
protein binding sites. Immunodetection of TPC1 and TPC2was achieved
using the anti-TPC1 and anti-TPC2 antibodies diluted 1:500 in TBST
overnight. The primary antibody was removed and blots were washed
six times for 5 min each with TBST. To detect the primary antibody,
blots were incubated for 45 min with the appropriate horseradish
peroxidase-conjugated secondary antibody diluted 1:10000 in TBST
and then exposed to enhanced chemiluminiscence reagents for 5 min.
Blots were then exposed to photographic ﬁlms. The density of bands
on the ﬁlm was measured using scanning densitometry.
2.6. Biotinylation of membrane proteins
MEG01 cells and adherent monolayers of cultured HEK-293 cells
grown in 75-cm2 tissue culture dishes were washed three times
Fig. 1. TPC1 and TPC2 are expressed in MEG01 and HEK-293 cells. Non-stimulated
MEG01 and HEK-293 cells were lysed and mRNA expression was determined by
RT-PCR. bp: pairs of bases. (A). Alternatively, lysateswere subjected toWestern blotting
using speciﬁc anti-TPC1 and anti-TPC2 antibodies (B and C). The results represented
three independent experiments.
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er, pH7.0 (16 mM-Na2HPO4 and 114 mM-NaH2PO4) and containing
2.5 mg EZ-Link sulfo-NHS-LC-biotin was added, and the cells were
incubated at 4 °C for 1 h. The biotinylation reaction was terminated
by addition of Tris-base to a ﬁnal concentration of 33 mM. Following
biotinylation, cells were washed twice in Sörensen's buffer, disrupted
using Nonidet P-40 buffer and sonicated. Cells were harvested by
centrifugation (16000×g, 5 min at 4 °C). Samples were incubated
with 25 μL streptavidin beads overnight at 4 °C and resuspended in
Laemmli's buffer for subsequent analysis by Western blotting.
2.7. Statistical analysis
Analysis of statistical signiﬁcance was performed using Student's
t-test. pb0.05 was considered to be signiﬁcant for a difference.
3. Results
3.1. TPC1 and TPC2 mRNA and protein are expressed in MEG01 and
HEK293 cells
Two ubiquitously expressed TPC proteins have been described, TPC1
and TPC2. TPC3 has been presented as a pseudogene in humans and
other primates [29,30] and appears to be absent in certain mammalian
cells [19]. To identify expression of TPC1 and TPC2 in MEG01 and
HEK293 cells we carried out RT-PCR. Semi-quantitative RT-PCR showed
a single PCR band for TPC1 and TPC2 indicating signiﬁcant expression of
their mRNA transcripts in the human cell lines MEG01 and HEK293
(Fig. 1A). We have further investigated the protein expression of TPC1
and TPC2 in these cells. As shown in Fig. 1B and C, Western blotting of
cell lysates with speciﬁc anti-TPC1 and TPC2 antibodies revealed the
presence of both proteins in MEG01 and HEK293 cells.
3.2. Silencing TPC2 expression attenuates TG-induced Ca2+ inﬂux
While the role of IP3 and ryanodine receptors on Ca2+ inﬂux has long
been described [31–33], the involvement of TPCs in the regulation of
Ca2+ ﬂuxes across the PM remains unknown. We have investigated
whether TPC1 and TPC2 channelsmodulate TG-evoked SOCEby silencing
TPC1 and TPC2 expression. As shown in Fig. 2A, top panels, shTPC1 and
shTPC2 reduced signiﬁcantly the amount of these proteins detected in
MEG01 cells by 81 and 77%, respectively, as compared with scRNA.
Western blotting with anti-actin antibody revealed a similar amount
of protein in all lanes (Fig. 2A, bottom panels).
Treatment of MEG01 cells with 1 μM TG resulted in a sustained
increase in [Ca2+]i due to passive Ca2+ efﬂux from the intracellular
Ca2+ stores. Subsequent addition of Ca2+ to the extracellular medium
induced a further increase in [Ca2+]i indicative of SOCE. Our results
indicate that shTPC1 and shTPC2 did not signiﬁcantly modify TG-
evoked Ca2+ release from the intracellular stores, as compared to
cells treated with scRNA (Fig. 2B and C; n=6); thus suggesting that
TPC1 and TPC2 silencing does not alter the ability of MEG01 cells to
accumulate Ca2+ in internal organelles. TPC1 silencing had a negligi-
ble effect, if any, in TG-induced SOCE in these cells. As shown in
Fig. 2B, the integral of the rise in [Ca2+]i for 2 min after the addition
of Ca2+ to the medium in shTPC1-treated cells was 97% of control.
Furthermore, TPC1 silencing did not modify the initial rate of increase
in [Ca2+]i upon Ca2+ addition (the initial slope of [Ca2+]i elevation
was 0.0482±0.0067 in control cells and 0.0439±0.0049 in shTPC1-
treated cells (n=6)). Interestingly, silencing of TPC2 expression
signiﬁcantly attenuated both the extent of TG-induced SOCE (the inte-
gral of the rise in [Ca2+]i for 2 min after the addition of Ca2+ to the
medium in shTPC2-treated cells was 67% of control; Fig. 2C; pb0.05;
n=6), as well as the initial rate of increase in [Ca2+]i upon Ca2+ addi-
tion (the initial slope was 0.0301±0.0037 in shTPC2-treated cells;
Fig. 2C; pb0.05; n=6).Similar results were found when we investigated the role of TPCs
in agonist-evoked Ca2+ mobilization in MEG01 cells. As shown in
Fig. 3, treatment of cells with thrombin (1 U/mL) resulted in a transient
increase in [Ca2+]i due to Ca2+ release from the intracellular stores
mediated by the generation of diffusible messengers. Subsequent addi-
tion of Ca2+ leads to a further [Ca2+]i elevation attributed to receptor-
operated Ca2+ entry mechanisms, including SOCE. Thrombin-evoked
Ca2+ entry was transient in contrast to the sustained effect induced
by TG, which does not allow intracellular stores to reﬁll. As shown in
Fig. 3, MEG01 cells treatment with shTPC1 and shTPC2 did not signiﬁ-
cantly modify thrombin-stimulated Ca2+ release from the intracellular
compartments, as compared to cells treated with scRNA. As for
TG-evoked SOCE, silencing of TPC2 expression resulted in attenuated
initial rate of [Ca2+]i elevation and reduced extent of Ca2+ entry. The
initial slope of [Ca2+]i elevation after stimulation with thrombin was
0.0578±0.0046 in control cells and 0.0431±0.0042 in shTPC2-
treated cells; Fig. 3C; pb0.05; n=6. In contrast, and in agreement
with the results reported for TG, TPC1 silencing was without effect on
thrombin-evoked Ca2+ entry (the initial slope of [Ca2+]i elevation
after stimulation with thrombin was 0.0591±0.0039 in shTPC1-
treated cells; Fig. 3B; n=6).
To conﬁrm the ﬁndings observed in MEG01 cells we investigated
the effect of TPC1 and TPC2 silencing in TG-induced SOCE in
HEK293 cells. Treatment of HEK293 cells with 1 μM TG resulted in a
sustained increase in [Ca2+]i due to Ca2+ leak from the intracellular
Fig. 2. Silencing TPC2 expression attenuates the rate and extent of Ca2+ inﬂux during SOCE in MEG01 cells. MEG01 cells were transfected with shTPC1, shTPC2 or control vector, as
indicated, and used after 48 h for protein detection. A, Western blotting showing the expression levels of TPC1 and TPC2, which was signiﬁcantly reduced in lysates from cells
transfected with shTPC1 (left panel) or shTPC2 (right panel). Bottom panel, Western blotting with anti-α actin antibody for protein loading control. B and C, MEG01 cells were
transfected with shTPC1 (B), shTPC2 (C) or control vector, as indicated. Cells were loaded with fura-2 and stimulated in a Ca2+-free medium (100 μM EGTA was added) with
1 μM TG, followed by addition of CaCl2 (ﬁnal concentration 600 μM) to initiate Ca2+ entry. Traces are representative of 6 independent experiments. Histograms represent
TG-induced Ca2+ release and Ca2+ entry expressed as percentage of Control (cells not treated with shTPC1 or shTPC2). Ca2+ release and entry was determined as described in
Materials and methods. Values are means±S.E.M.; signiﬁcance values indicate differences compared with TG-treated cells in the absence of shTPC2. *pb0.05.
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medium resulted in a further increase in [Ca2+]i indicative of SOCE.
As for MEG01 cells, our results indicate that treatment of HEK293
cells with shTPC1 and shTPC2 did not signiﬁcantly alter TG-evoked
Ca2+ release from the intracellular stores, as compared to cells treat-
ed with scRNA (Fig. 4A and B; n=6); thus indicating that TPC1 and
TPC2 silencing does not interfere with the ability of HEK293 cells to
accumulate Ca2+ into TG-sensitive stores. In agreement with results
reported above, TPC1 silencing did not signiﬁcantly modify either
the extent of TG-induced SOCE (the integral of the rise in [Ca2+]i
for 2 min after the addition of Ca2+ to the medium in shTPC1-
treated cells was 111% of control) or the initial rate of increase in
[Ca2+]i upon Ca2+ addition (the initial slope of [Ca2+]i elevation
was 0.0401±0.0033 in control cells and 0.0432±0.0042 in shTPC1-
treated cells; Fig. 4A; n=6). In contrast, silencing of TPC2 expressionsigniﬁcantly attenuated both the extent of TG-induced SOCE (the
integral of the rise in [Ca2+]i for 2 min after the addition of Ca2+ to
the medium in shTPC2-treated cells was 55% of control; Fig. 4B;
pb0.05; n=6), as well as the initial rate of increase in [Ca2+]i upon
Ca2+ addition (the initial slope was 0.0211±0.0027 in shTPC2-treated
cells; Fig. 4B; pb0.05; n=6).
3.3. TPC1 and TPC2 are not expressed in the plasma membrane
To investigate whether the modulatory effect of TPC2 on SOCE and
agonist-stimulated Ca2+ entry is mediated by their presence in the
PM, we assessed the surface expression of TPC1 and TPC2 in resting
MEG01 and HEK293 cells by biotinylation of PM proteins and collec-
tion with streptavidin-coated agarose beads. SDS-PAGE and Western
blotting were used to identify TPC1, TPC2 and Orai1, a SOC subunit
Fig. 3. Silencing TPC2 expression attenuates the rate and extent of Ca2+ inﬂux stimulated by thrombin in MEG01 cells. MEG01 cells were transfected with shTPC1, shTPC2 or control
vector, as indicated, and used after 48 h for protein detection. A and B, MEG01 cells were transfected with shTPC1 (A), shTPC2 (B) or control vector, as indicated. Cells were loaded
with fura-2 and stimulated in a Ca2+-free medium (100 μM EGTA was added) with 1 U/mL thrombin, followed by addition of CaCl2 (ﬁnal concentration 600 μM) to initiate Ca2+
entry. Traces are representative of 6 independent experiments. Histograms represent thrombin-induced Ca2+ release and Ca2+ entry expressed as percentage of Control (cells not
treated with shTPC1 or shTPC2). Ca2+ release and entry was determined as described in Materials and methods. Values are means±S.E.M.; signiﬁcance values indicate differences
compared with TG-treated cells in the absence of shTPC2. *pb0.05.
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Fig. 5, analysis of biotinylated proteins shows that Orai1 is present in
the PM in resting MEG01 and HEK-293 cells. In contrast, we were
unable to detect TPC1 and TPC2 in the PMunder the same experimental
conditions (Fig. 5; n=4); thus indicating that TPC1 and TPC2 are
expressed in the membrane of internal organelles, as previously
described [18,36,37].3.4. TPC2 co-immunoprecipitates with STIM1 and Orai1 but not with
TRPC1 in MEG01 cells
In order to explore the mechanism underlying the modulation of
SOCE by TPC2 we investigated its association with STIM1, Orai1 and
TRPC1 by looking for co-immunoprecipitation from MEG01 lysates.
Immunoprecipitation and subsequent SDS/PAGE andWestern blotting
were conducted using resting cells and cells in which the intracellular
Ca2+ stores had been depleted by 3 min of pretreatment with TG
(1 μM) in the absence of extracellular Ca2+ (100 μM EGTA). After
immunoprecipitation with the anti-STIM1 antibody, Western blotting
revealed the presence of TPC2 in samples from store-depleted, but not
resting cells (Fig. 6B, top panel; n=5), while TPC1 was undetectable
in samples from either resting or store-depleted cells (Fig. 6A, top
panel; n=5), which is consistent with a role for TPC2, but not TPC1,
in the regulation of SOCE, as reported above. Western blotting with
anti-STIM1 antibody conﬁrmed a similar content of this protein in all
lanes (Fig. 6A and B, bottom panels). We also conducted experiments
on immunoprecipitating MEG01 cell lysates under resting or TG-
stimulated conditions with either anti-Orai1 or anti-TRPC1 antibody.After immunoprecipitation with anti-Orai1, TPC2 was detected in sam-
ples from store-depleted, but not restingMEG01 cells (Fig. 6C, top panel;
n=5); however, after immunoprecipitation with anti-TRPC1 TPC2 was
undetectable in samples from control or TG-treated samples (Fig. 6D,
top panel; n=5). Immunoblot analysis of anti-Orai1 or anti-TRPC1
immunoprecipitates with the same antibodies, as appropriate, revealed
a similar content of these proteins in the relevant lanes (Fig. 6C and D,
bottom panels; n=5).4. Discussion
Cytosolic Ca2+ concentration is modiﬁed by a vast number of
agonists in order to regulate cellular function. Agonist-receptor inter-
action leads to the generation of distinct intracellular Ca2+-releasing
molecules, among them, NAADP has been identiﬁed as the most
potent Ca2+-mobilizing messenger described [38,39]. NAADP has
been reported to regulate different ion channels, including the type I
ryanodine receptor [40] and TRP-ML1 (transient receptor potential
channel, subtype mucolipin 1) [41]. More recently, a number of
studies demonstrated that TPCs are NAADP-regulated Ca2+ channels
[18,20,42]. TPCs are located in endosomes and lysosome-related
organelles, although TPC2 has been reported as the major lysosomal
targeted isoform [43]. SOCE is a receptor-operated Ca2+ inﬂux mecha-
nism controlled by the amount of Ca2+ accumulated into agonist-
sensitive compartments, mostly described as the ER and lysosomal-
related (acidic) organelles [23,44], both expressing the Ca2+ sensor
STIM1 [3,7]. However, despite SOCE is activated by discharge of the
lysosomal-related organelles, where Ca2+ efﬂux via the TPCs/NAADP
Fig. 4. Silencing TPC2 expression attenuates the rate and extent of Ca2+ inﬂux during SOCE in HEK293 cells. HEK293 cells were transfected with shTPC1, shTPC2 or control vector, as
indicated, and used after 48 h for protein detection. A and B, cells were transfected with shTPC1 (A), shTPC2 (B) or control vector, as indicated. Cells were loaded with fura-2 and
stimulated in a Ca2+-free medium (100 μM EGTA was added) with 1 μM TG, followed by addition of CaCl2 (ﬁnal concentration 600 μM) to initiate Ca2+ entry. Traces are represen-
tative of 6 independent experiments. Histograms represent TG-induced Ca2+ release and Ca2+ entry expressed as percentage of Control (cells not treated with shTPC1 or shTPC2).
Ca2+ release and entry was determined as described in Materials and methods. Values are means±S.E.M.; signiﬁcance values indicate differences compared with TG-treated cells in
the absence of shTPC2. *pb0.05.
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SOCE has not been evaluated yet. Our results show, for the ﬁrst time,
that silencing of the expression of endogenous TPC2 is able to attenuate
both the initial rate of Ca2+ entry and the extent of SOCE stimulated
by TG, without affecting the ability of cells to accumulate Ca2+ into
the intracellular stores, in two unrelated human cell lines, the
megakaryoblastic MEG01 cells and HEK293 cells. In contrast, signiﬁcantFig. 5. TPC1 and TPC2 are not expressed in the plasma membrane in MEG01 and HEK2
with ice-cold Söerscen's buffer and cell surface proteins were labeled by biotinylation, extra
blotting using the anti-Orai1, anti-TPC1 and anti-TPC2 antibodies. Positions of molecular mattenuation of endogenous TPC1 expression in both cell lines was
unable to modify either TG-induced Ca2+ release from the stores or
TG-stimulated SOCE. TG was used to induce passive store depletion by
inhibition of Ca2+ reuptake into the agonist-sensitive stores by the
sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), whose expression
has been demonstrated in the ER, endosomes and lysosomal-related
organelles [45]. We have further found that silencing TPC2, but not93 cells. HEK293 (A) and MEG01 cells (B) under resting conditions were incubated
cted with streptavidin-coated agarose beads, and analyzed by SDS-PAGE and Western
ass markers are shown on the left.
Fig. 6. TPC2 co-immunoprecipitates with STIM1 and Orai1 in MEG01 cells. Cells were
stimulated with 1 μM TG for 3 min or the vehicle, as control, and lysed. Whole cell ly-
sates were immunoprecipitated (IP) with anti-STIM1 antibody (A and B), anti-Orai1
antibody (C) or anti-TRPC1 antibody (D). Immunoprecipitates were subjected to 10%
SDS-PAGE and subsequent Western blotting with speciﬁc anti-TPC1 antibody (A) or
anti-TPC2 antibody (B–D). Membranes were reprobed with the antibody used for
immunoprecipitation for protein loading control. The panel shows results from one
experiment representative of 4 others. Molecular masses indicated on the right were
determined using molecular-mass markers run in the same gel.
1982 J.J. López et al. / Biochimica et Biophysica Acta 1823 (2012) 1976–1983TPC1, expression reduces Ca2+ entry by the physiological agonist
thrombin. The lack of effect of alternative silencing of TPC1 and TPC2
expression on thrombin-stimulated Ca2+ release might be attributed
to different factors: i) thrombin is unable to generate signiﬁcant
amounts of NAADP to induce a detectable signal; ii) the effect of the
attenuation of TPC1 or TPC2 expression on thrombin-evoked Ca2+
release is overcome by the actions of other intracellular channels,
including the IP3 or ryanodine receptors (MEG01 cells have been
reported to express IP3 receptors types I, II and III [46] and the type III
ryanodine receptor [47]).
We have explored the mechanism underlying the modulation of
SOCE by TPC2 and tested the presence of TPCs in the PM, where the
SOCs are located. Biotinylation analysis conﬁrmed that TPCs are not
expressed in the PM. Our results also report for the ﬁrst time that
discharge of the intracellular Ca2+ stores using TG leads to the association
of TPC2 with the Ca2+ sensor STIM1 and Ca2+ channel Orai1; however,we did not detect association of TPC2 with TRPC1. The interaction of
TPC2with STIM1andOrai1was only found in cellswhere the Ca2+ stores
had been depleted using TG and not in resting, undepleted, cells, which
suggest that this is a de novo association whose activation shows paral-
lelismwith that of SOCE. The association of TPC2with STIM1 upon store
depletion strongly suggests that TPC2 plays a relevant role in the regu-
lation of SOCE. Although speculative, rapid Ca2+ efﬂux mediated by
TPC2 in the close proximity of STIM1 might inﬂuence the rate and
extent of SOCE activation by the latter, which would explain the atten-
uation of the initial rate and extent of SOCE found upon silencing TPC2
expression. The TPC2-Orai1 association might occur either directly or
indirectly and mediated by STIM1, and this interaction might also be
important for the regulation of SOCE by TPC2.
The involvement of TPC2, but not TPC1, in the modulation of SOCE
might be attributed to the distinct distribution of TPCs in human cells,
with TPC2 predominantly located in lysosomal-related organelles
[18,20,43]. In addition, relevant functional differences between TPC1
and TPC2 have been described. While Ca2+ release through both
receptor/channels are regulated by NAADP, the subsequent ampliﬁca-
tion of this Ca2+ signal by IP3 receptors, which are also involved in
the regulation of SOCE [48], is more tightly coupled for TPC2 [29].
Our ﬁndings provide the ﬁrst evidence for a role for TPC2 in the
modulation of SOCE. The new role of TPC2 might be mediated by
colocalization with STIM1 in internal stores, which might modify
the kinetics of STIM1-Ca2+ binding and, thus, Ca2+ sensing and the
activation rate and extent of SOCE.Acknowledgements
We are very grateful to Doctor Sandip Patel for providing us with
TPC1 and TPC2 shRNA plasmids. This work was supported by MICINN
grant BFU2010-21043-C02-01 and Junta de Extremadura (GR10010).
N.D. held a fellowship from Junta de Extremadura (PRE09020).References
[1] J.W. Putney Jr., Recent breakthroughs in the molecular mechanism of capacitative
calcium entry (with thoughts on how we got here), Cell Calcium 42 (2007)
103–110.
[2] J. Liou, M.L. Kim, W.D. Heo, J.T. Jones, J.W. Myers, J.E. Ferrell Jr., T. Meyer, STIM is a
Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ inﬂux, Curr. Biol.
15 (2005) 1235–1241.
[3] J. Roos, P.J. DiGregorio, A.V. Yeromin, K. Ohlsen, M. Lioudyno, S. Zhang, O. Safrina, J.A.
Kozak, S.L.Wagner, M.D. Cahalan, G. Velicelebi, K.A. Stauderman, STIM1, an essential
and conserved component of store-operated Ca2+ channel function, J. Cell Biol. 169
(2005) 435–445.
[4] S.L. Zhang, Y. Yu, J. Roos, J.A. Kozak, T.J. Deerinck, M.H. Ellisman, K.A. Stauderman,
M.D. Cahalan, STIM1 is a Ca2+ sensor that activates CRAC channels and migrates
from the Ca2+ store to the plasma membrane, Nature 437 (2005) 902–905.
[5] S.S. Manji, N.J. Parker, R.T. Williams, L. van Stekelenburg, R.B. Pearson, M. Dziadek,
P.J. Smith, STIM1: a novel phosphoprotein located at the cell surface, Biochim.
Biophys. Acta 1481 (2000) 147–155.
[6] R.M. Luik, B. Wang, M. Prakriya, M.M. Wu, R.S. Lewis, Oligomerization of STIM1
couples ER calcium depletion to CRAC channel activation, Nature 454 (2008)
538–542.
[7] H. Zbidi, I. Jardin, G.E. Woodard, J.J. Lopez, A. Berna-Erro, G.M. Salido, J.A. Rosado,
STIM1 and STIM2 are located in the acidic Ca2+ stores and associates with Orai1
upon depletion of the acidic stores in human platelets, J. Biol. Chem. 286 (2011)
12257–12270.
[8] J. Soboloff, M.A. Spassova, X.D. Tang, T. Hewavitharana, W. Xu, D.L. Gill, Orai1 and
STIM reconstitute store-operated calcium channel function, J. Biol. Chem. 281
(2006) 20661–20665.
[9] P.F. Worley, W. Zeng, G.N. Huang, J.P. Yuan, J.Y. Kim, M.G. Lee, S. Muallem, TRPC
channels as STIM1-regulated store-operated channels, Cell Calcium 42 (2007)
205–211.
[10] J.P. Yuan,W. Zeng, G.N. Huang, P.F.Worley, S. Muallem, STIM1 heteromultimerizes
TRPC channels to determine their function as store-operated channels, Nat. Cell
Biol. 9 (2007) 636–645.
[11] G.B. Montalvo, A.R. Artalejo, J.A. Gilabert, ATP from subplasmalemmal mitochon-
dria controls Ca2+-dependent inactivation of CRAC channels, J. Biol. Chem. 281
(2006) 35616–35623.
[12] J.A. Gilabert, A.B. Parekh, Respiring mitochondria determine the pattern of activa-
tion and inactivation of the store-operated Ca(2+) current I(CRAC), EMBO J. 19
(2000) 6401–6407.
1983J.J. López et al. / Biochimica et Biophysica Acta 1823 (2012) 1976–1983[13] H. Jousset, M. Frieden, N. Demaurex, STIM1 knockdown reveals that store-
operated Ca2+ channels located close to sarco/endoplasmic Ca2+ ATPases
(SERCA) pumps silently reﬁll the endoplasmic reticulum, J. Biol. Chem. 282
(2007) 11456–11464.
[14] I.M. Manjarres, A. Rodriguez-Garcia, M.T. Alonso, J. Garcia-Sancho, The
sarco/endoplasmic reticulum Ca(2+) ATPase (SERCA) is the third element in
capacitative calcium entry, Cell Calcium 47 (2010) 412–418.
[15] P. Chavis, L. Fagni, J.B. Lansman, J. Bockaert, Functional coupling between
ryanodine receptors and L-type calcium channels in neurons, Nature 382
(1996) 719–722.
[16] K. Kiselyov, G.A. Mignery, M.X. Zhu, S. Muallem, The N-terminal domain of the IP3
receptor gates store-operated hTrp3 channels, Mol. Cell 4 (1999) 423–429.
[17] J.A. Rosado, S.O. Sage, Coupling between inositol 1,4,5-trisphosphate receptors
and human transient receptor potential channel 1 when intracellular Ca2+ stores
are depleted, Biochem. J. 350 (Pt 3) (2000) 631–635.
[18] P.J. Calcraft, M. Ruas, Z. Pan, X. Cheng, A. Arredouani, X. Hao, J. Tang, K. Rietdorf, L.
Teboul, K.T. Chuang, P. Lin, R. Xiao, C. Wang, Y. Zhu, Y. Lin, C.N. Wyatt, J.
Parrington, J. Ma, A.M. Evans, A. Galione, M.X. Zhu, NAADP mobilizes calcium
from acidic organelles through two-pore channels, Nature 459 (2009) 596–600.
[19] S. Patel, J.S. Marchant, E. Brailoiu, Two-pore channels: regulation by NAADP and
customized roles in triggering calcium signals, Cell Calcium 47 (2010) 480–490.
[20] E. Brailoiu, D. Churamani, X. Cai, M.G. Schrlau, G.C. Brailoiu, X. Gao, R. Hooper, M.J.
Boulware, N.J. Dun, J.S. Marchant, S. Patel, Essential requirement for two-pore
channel 1 in NAADP-mediated calcium signaling, J. Cell Biol. 186 (2009) 201–209.
[21] N.P. Kinnear, F.X. Boittin, J.M. Thomas, A. Galione, A.M. Evans, Lysosome-sarcoplasmic
reticulum junctions. A trigger zone for calcium signaling by nicotinic acid adenine
dinucleotide phosphate and endothelin-1, J. Biol. Chem. 279 (2004) 54319–54326.
[22] M. Yamasaki, R. Masgrau, A.J. Morgan, G.C. Churchill, S. Patel, S.J. Ashcroft, A.
Galione, Organelle selection determines agonist-speciﬁc Ca2+ signals in pancre-
atic acinar and beta cells, J. Biol. Chem. 279 (2004) 7234–7240.
[23] J.A. Rosado, J.J. Lopez, A.G. Harper, M.T. Harper, P.C. Redondo, J.A. Pariente, S.O.
Sage, G.M. Salido, Two pathways for store-mediated calcium entry differentially
dependent on the actin cytoskeleton in human platelets, J. Biol. Chem. 279
(2004) 29231–29235.
[24] Y. Lin-Moshier, T.F. Walseth, D. Churamani, S.M. Davidson, J.T. Slama, R. Hooper,
E. Brailoiu, S. Patel, J.S. Marchant, Photoafﬁnity labeling of nicotinic acid adenine
dinucleotide phosphate (NAADP) targets in mammalian cells, J. Biol. Chem. 287
(2012) 2296–2307.
[25] T.F. Walseth, Y. Lin-Moshier, P. Jain, M. Ruas, J. Parrington, A. Galione, J.S.
Marchant, J.T. Slama, Photoafﬁnity labeling of high afﬁnity nicotinic acid adenine
dinucleotide phosphate (NAADP)-binding proteins in sea urchin egg, J. Biol.
Chem. 287 (2012) 2308–2315.
[26] I. Jardin, P.C. Redondo, G.M. Salido, J.A. Rosado, Phosphatidylinositol 4,5-
bisphosphate enhances store-operated calcium entry through hTRPC6 channel
in human platelets, Biochim. Biophys. Acta 1783 (2008) 84–97.
[27] P.C. Redondo, N. Ben-Amor, G.M. Salido, A. Bartegi, J.A. Pariente, J.A. Rosado,
Ca2+−independent activation of Bruton's tyrosine kinase is required for store-
mediated Ca2+ entry in human platelets, Cell. Signal. 17 (2005) 1011–1021.
[28] P.C. Redondo, I. Jardin, J.J. Lopez, G.M. Salido, J.A. Rosado, Intracellular Ca2+ store
depletion induces the formation of macromolecular complexes involving hTRPC1,
hTRPC6, the type II IP3 receptor and SERCA3 in human platelets, Biochim.
Biophys. Acta 1783 (2008) 1163–1176.
[29] M. Ruas, K. Rietdorf, A. Arredouani, L.C. Davis, E. Lloyd-Evans, H. Koegel, T.M.
Funnell, A.J. Morgan, J.A. Ward, K. Watanabe, X. Cheng, G.C. Churchill, M.X. Zhu,
F.M. Platt, G.M. Wessel, J. Parrington, A. Galione, Puriﬁed TPC isoforms form
NAADP receptors with distinct roles for Ca2+ signaling and endolysosomal traf-
ﬁcking, Curr. Biol. 20 (2010) 703–709.
[30] E. Brailoiu, R. Hooper, X. Cai, G.C. Brailoiu, M.V. Keebler, N.J. Dun, J.S. Marchant, S.
Patel, An ancestral deuterostome family of two-pore channels mediates nicotinicacid adenine dinucleotide phosphate-dependent calcium release from acidic or-
ganelles, J. Biol. Chem. 285 (2010) 2897–2901.
[31] M.D. Stern, Theory of excitation–contraction coupling in cardiac muscle, Biophys.
J. 63 (1992) 497–517.
[32] G. Boulay, D.M. Brown, N. Qin, M. Jiang, A. Dietrich, M.X. Zhu, Z. Chen, M.
Birnbaumer, K. Mikoshiba, L. Birnbaumer, Modulation of Ca(2+) entry by poly-
peptides of the inositol 1,4, 5-trisphosphate receptor (IP3R) that bind transient
receptor potential (TRP): evidence for roles of TRP and IP3R in store
depletion-activated Ca(2+) entry, Proc. Natl. Acad. Sci. U. S. A. 96 (1999)
14955–14960.
[33] J.A. Rosado, S.L. Brownlow, S.O. Sage, Endogenously expressed Trp1 is involved in
store-mediated Ca2+ entry by conformational coupling in human platelets, J. Biol.
Chem. 277 (2002) 42157–42163.
[34] S. Feske, Y. Gwack, M. Prakriya, S. Srikanth, S.H. Puppel, B. Tanasa, P.G. Hogan, R.S.
Lewis, M. Daly, A. Rao, A mutation in Orai1 causes immune deﬁciency by abrogat-
ing CRAC channel function, Nature 441 (2006) 179–185.
[35] G.E. Woodard, G.M. Salido, J.A. Rosado, Enhanced exocytotic-like insertion of
Orai1 into the plasma membrane upon intracellular Ca2+ store depletion, Am. J.
Physiol. Cell Physiol. 294 (2008) C1323–C1331.
[36] G.C. Brailoiu, B. Gurzu, X. Gao, R. Parkesh, P.K. Aley, D.I. Trifa, A. Galione, N.J. Dun,
M. Muniswamy, S. Patel, G.C. Churchill, E. Brailoiu, Acidic NAADP-sensitive calci-
um stores in the endothelium: agonist-speciﬁc recruitment and role in regulating
blood pressure, J. Biol. Chem. 285 (2010) 37133–37137.
[37] G.C. Churchill, Y. Okada, J.M. Thomas, A.A. Genazzani, S. Patel, A. Galione, NAADP
mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea
urchin eggs, Cell 111 (2002) 703–708.
[38] H.C. Lee, R. Aarhus, A derivative of NADP mobilizes calcium stores insensitive to
inositol trisphosphate and cyclic ADP-ribose, J. Biol. Chem. 270 (1995) 2152–2157.
[39] J.M. Cancela, G.C. Churchill, A. Galione, Coordination of agonist-induced
Ca2+-signalling patterns by NAADP in pancreatic acinar cells, Nature 398 (1999)
74–76.
[40] M. Hohenegger, J. Suko, R. Gscheidlinger, H. Drobny, A. Zidar, Nicotinic
acid-adenine dinucleotide phosphate activates the skeletal muscle ryanodine re-
ceptor, Biochem. J. 367 (2002) 423–431.
[41] F. Zhang, P.L. Li, Reconstitution and characterization of a nicotinic acid adenine di-
nucleotide phosphate (NAADP)-sensitive Ca2+ release channel from liver lyso-
somes of rats, J. Biol. Chem. 282 (2007) 25259–25269.
[42] X. Zong, M. Schieder, H. Cuny, S. Fenske, C. Gruner, K. Rotzer, O. Griesbeck, H.
Harz, M. Biel, C. Wahl-Schott, The two-pore channel TPCN2 mediates NAADP-
dependent Ca(2+)-release from lysosomal stores, Pﬂugers Arch. 458 (2009)
891–899.
[43] S.J. Pitt, T.M. Funnell, M. Sitsapesan, E. Venturi, K. Rietdorf, M. Ruas, A. Ganesan, R.
Gosain, G.C. Churchill, M.X. Zhu, J. Parrington, A. Galione, R. Sitsapesan, TPC2 is a
novel NAADP-sensitive Ca2+ release channel, operating as a dual sensor of lumi-
nal pH and Ca2+, J. Biol. Chem. 285 (2010) 35039–35046.
[44] C.Y. Kwan, H. Takemura, J.F. Obie, O. Thastrup, J.W. Putney Jr., Effects of MeCh,
thapsigargin, and La3+ on plasmalemmal and intracellular Ca2+ transport in
lacrimal acinar cells, Am. J. Physiol. 258 (1990) C1006–C1015.
[45] F. Wuytack, L. Dode, F. Baba-Aissa, L. Raeymaekers, The SERCA3-type of organellar
Ca2+ pumps, Biosci. Rep. 15 (1995) 299–306.
[46] C. Lacabaratz-Porret, S. Launay, E. Corvazier, R. Bredoux, B. Papp, J. Enouf, Biogenesis
of endoplasmic reticulum proteins involved in Ca2+ signalling during megakaryo-
cytic differentiation: an in vitro study, Biochem. J. 350 (Pt 3) (2000) 723–734.
[47] E. Hosoi, C. Nishizaki, K.L. Gallagher, H.W. Wyre, Y. Matsuo, Y. Sei, Expression of
the ryanodine receptor isoforms in immune cells, J. Immunol. 167 (2001)
4887–4894.
[48] I. Jardin, J.J. Lopez, G.M. Salido, J.A. Rosado, Functional relevance of the de novo
coupling between hTRPC1 and type II IP3 receptor in store-operated Ca2+ entry
in human platelets, Cell. Signal. 20 (2008) 737–747.
